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active components of Huangqin Tang (HQT, a traditional Chinese medicine formula). In this study, we used a
combinative method approach consisting of chromatographic ﬁngerprinting (high performance liquid
chromatography; HPLC), quantitative methods and a pharmacodynamic evaluation model to analyze the
ﬂavonoids of HQT obtained from different sources. Ten batches of HQT were analyzed by the HPLC
ﬁngerprinting method and 26 common peaks were detected, of which 23 peaks corresponded with the chemical
proﬁle of HQT. In addition, 11 major compounds were identiﬁed by LC–MS analysis (liquid chromatography–
tandem mass spectrometer; LC–MSn) and quantiﬁed by the HPLC quantitative method approach. The studied
10 batches of HQT were found to be homogeneous in their composition with a similarity between 0.990 and
1.000. The distribution of the 11 identiﬁed compounds was found to be very similar among the batches. Only
slight pharmacodynamic differences were detected between the different batches, conﬁrming the homogeneity
of HQT. The results of this study prove that the combination of chromatographic ﬁngerprinting and quantitative
analysis can be readily used for comprehensive quality control of herbal medicines.
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Flavonoid proﬁling of Huangqin Tang 1491. Introduction
Traditional Chinese medicine (TCM), especially herbal medicine,
is gaining increasing attention worldwide for its millennia-old
practices and its potential all-natural therapeutic applications.
Huangqin Tang (HQT), a well-known Chinese medicine formula,
is a combination of four herbal medicines 3:2:2:2 by weight,
namely Radix Scutellariae (Scutellaria baicalensis Georgi), Radix
Paeoniae Alba (Paeonia lactiﬂora Pall.), Radix et Rhizoma
Glycyrrhizae (Glycyrrhiza uralensis Fisch., Glycyrrhiza inﬂata
Bat. or Glycyrrhiza glabra L.) and Fructus Jujubae (Ziziphus
jujuba Mill). HQT has traditionally been used for the treatment of
colds and gastrointestinal diseases with symptoms of fever,
abdominalgia and diarrhea1,2. Recently, some studies have
reported that PHY906, an extract derived from HQT, reduces
gastrointestinal toxicity and enhances the anti-tumor effect of some
anti-cancer drugs3,4. This extract has been studied in ﬁve clinical
trials with patients suffering from different types of cancer in both
the US and Taiwan with very encouraging results. Radix Scutel-
lariae, the chief ingredient of HQT, has been widely used in TCM
prescriptions5. It is known to be effective in the treatment of fever,
inﬂammation, cancers and other gastrointestinal diseases6–9. The
major functional constituents of Radix Scutellariae are ﬂavonoid
glycosides (e.g., baicalin, wogonoside and oroxylin-A-glucoside)
and ﬂavonoids (e.g., baicalein, wogonin and oroxylin-A)10–12.
Phytochemical studies have shown that the main constituents of
the other three herbs (Radix Paeoniae Alba, Radix et Rhizoma
Glycyrrhizae and Fructus Jujubae) are ﬂavones, isoﬂavones,
terpenoids, volatile oils and polysaccharides with a wide range
of pharmacological properties13–15, such as anti-inﬂammatory,
analgesic, antitussive, tumor suppressor and immunomodula-
tory16–19. Flavonoids are the important effective components
from HQT.
Generally, the chemical composition of herbal formulations may
vary greatly due to differences in plant origins, cultivation areas and
practices, climate conditions and processing protocols among others20–
22. This leads to wide disparities in quality among different samples.
An effective and feasible method should take the complexity and
variability of the chemical constituents of herbal medicines into
consideration simultaneously. However, previous studies addressing
HQT using ﬁngerprinting analysis failed to include enough quality
control markers or had a limited study sample population23,24. Here
we use a combinatorial approach with chromatographic ﬁngerprin-
ting analysis, a multiple-component quantitative analysis and animal
pharmacology to comprehensively assess the quality of different HQT
samples.Table 1 Huangqin Tang samples used in the study and their calcula
Sample
No.
Batch
No.
Collection site of Radix Scutellariae O
S1 20120427 Beijing Tianheng Pharmacy N
S2 20120519 Beijing Tongzhitang Pharmacy N
S3 20120512 Beijing Tongrentang Pharmacy N
S4 20120522 Beijing Hedantang Pharmacy N
S5 20120523 Beijing Jinxiang Pharmacy H
S6 20120519 Beijing Yongantang Pharmacy H
S7 20120427 Beijing Xingainian Pharmacy H
S8 20120512 Beijing Wukesong Clinic H
S9 20120523 Beijing Jingzhitang Pharmacy S
S10 20120426 Beijing Jinglongtang Pharmacy S2. Materials and methods
2.1. Chemicals and herbal materials
The reference standards for baicalin, wogonoside, oroxylin-A-
glucoside, baicalein, wogonin, oroxylin-A, liquiritin, liquiritigenin,
isoliquiritoside, isoliquiritigenin, liquiritin apioside and isoliquiri-
tin apioside were purchased from Zelang Pharmaceuticals (Nanj-
ing, China). The purity of these compounds was higher than 98%
by HPLC analysis based on a peak area normalization method.
Aspirin (Scientiﬁc Research Special) and carrageenin (Sigma Life
Science), both in pure powdered form, were also used. Analytical-
grade ethanol and acetic acid were purchased from Beijing
Chemical Factory (Beijing, China). HPLC-grade methanol and
acetonitrile were obtained from Fisher (Fisher Scientiﬁc, USA).
Puriﬁed water was purchased from Wahaha Group (Hangzhou,
China).
Crude Radix Scutellariae from three origins that met the
requirements of Beijing Food and Drug Administration was
collected from different pharmacies in Beijing. Crude Radix
Rhizoma Glycyrrhizae, Radix Paeoniae and Fructus Jujubae
(Herbal Pieces Co., Ltd.; originally from Anhui, Neimeng and
Hebei, respectively) were collected from Beijing Wukesong
Clinic. The source and labeling of the medicines is summarized
in Table 1. All herbal medicines were identiﬁed by Professor
Xianduan Li of the Institute of Chinese Materia Medica, China
Academy of Chinese Medical Sciences and voucher specimens
were deposited in the institute. HPLC analysis was used to conﬁrm
that the content of baicalin in crude Radix Scutellariaeis is
14.972.7% in accordance with the quality level request of 4.0%
established in the Chinese Pharmacopoeia 20105.2.2. Preparation of HQT granule, HQT sample solutions and
standard solutions
Ten batches of crude Radix Scutellariae (9 g) and one batch of
Radix et Rhizoma Glycyrrhizae (6 g), Radix Paeoniae (6 g) and
Fructus Jujubae (6 g) were weighed and thoroughly soaked in
water for 30 min. For the ﬁrst decoction, 10-fold water (1:10 w/v)
was added to the crude drugs and the mixture was boiled for 1.5 h,
after which the decoction was ﬁltered. At this point, 8-fold water
(1:8 w/v) was added to the crude drug residue. Then the mixture
was boiled for additional 1 h. Following ﬁltration, the decoction
was combined with previous one and the sample was dried in a
vacuum oven at 60 1C into a granulated powder which wasted similarity values.
rigin of Radix Scutellariae Ratio extraction (%) Similarity
eimeng 39.39 1.000
eimeng 33.22 0.998
eimeng 32.56 0.990
eimeng 32.67 0.997
ebei 32.11 0.996
ebei 33.78 0.999
ebei 38.89 0.999
ebei 36.00 0.998
hanxi 33.67 0.999
hanxi 33.56 0.999
Tao Li et al.150packaged and stored at 4 1C for future use. Ratio extraction was
calculated using the following formula:
Ratio extraction %ð Þ ¼W1=W2  100 ð1Þ
where W1 is the weight of the dried HQT granules and W2 is the
weight of the crude HQT mixture.
Dried HQT granules (approximately 0.50 g) were ground into a
powder (approximately 40 meshes) and weighed. For phytochem-
ical analysis, the HQT powder was extracted with 50 mL of 75%
(w/v) ethanol in a water bath at 80 1C for 30 min with one shaking
every 15 min. After adjusting to ambient temperature, ethanol was
then added to compensate for the lost weight during the extraction.
Finally, the supernatant was ﬁltered through a 0.22 mm membrane
ﬁlter and injected into the HPLC and LC–MS system for analysis.
For animal experiments, the HQT powder was dissolved in water
at a temperature of 80 1C and shaken to a ﬁnal nominal
concentration of 0.5 mg dry weight HQT powder extract per mL
of water.
The following standard stock solutions were prepared in
methanol, stored at 4 1C, and diluted as required for their use in
the calibration curves: baicalin (2074.00 mg/L), wogonoside
(1200.00 mg/L), oroxylin-A-glucoside (750.00 mg/L), baicalein
(270.00 mg/L), wogonin (72.00 mg/L), oroxylin-A (27.20 mg/L),
liquiritin (299.00 mg/L), liquiritigenin (129.00 mg/L), isoliquirito-
side (6.29 mg/L), isoliquiritigenin (6.43 mg/L), liquiritin apioside
(24.90 mg/L) and isoliquiritin apioside (2.94 mg/L).
2.3. HPLC and LC–MS analysis
HPLC analysis was performed on a Shimadzu LC-20A system
(Kyoto, Japan) equipped with an SPD-20A photodiode array
detector. The analytes were separated on a Dikma Diamonsil
C18 column (250 mm 4.6 mm, 5 μm). The mobile phase con-
sisted of A (acetonitrile) and B (water containing 1% acetic acid).
The linear gradient conditions were optimized as follows: 0–
13 min, 17% A; 13–15 min, 17%–20% A; 15–50 min, 20%–30%
A; 50–62 min, 30%–40% A; 62–70 min, 40%–44% A; 70–80 min,
44%–100% A. The ﬂow rate was 1.0 mL/min at 35 1C. UV
absorbance was monitored at 276 nm for ﬁngerprinting analysis
and 276 nm and 370 nm simultaneously for the quantitative
analysis.
LC–MSn analysis was performed on an Aglient Ion Trap6320
mass spectrometer system with an electrospray ion source (ESI)
(Applied Biosystems, Toronto, Canada). The LC conditions used
for LC–MSn analysis were the same as those used for the HPLC
analysis described above. The optimized MS conditions were ﬁxed
as follows: positive ions and negative ions mode was applied. The
gas system was set as follows: nebulizer (N2), 42 psi; dry gas (N2),
12 L/min; dry temp., 350 1C. Helium was used as collision gas
(compound stability: 100%; trap level: 100%; scan range: 100–
1500 Da). The injection volume was 10 mL and all solutions were
ﬁltered through a syringe ﬁlter (0.22 mm) before analysis.
2.4. Method validation
HPLC ﬁngerprinting analysis was developed and its precision,
stability and repeatability were validated according to the estab-
lished guidelines of the China Food and Drug Administration
(CFDA) of China25. Precision was determined by analyzing the
ﬁve replicates of a sample of an HQT-S1 solution on the same day.
To conﬁrm the repeatability of results, ﬁve different samplesolutions prepared from the same sample (HQT-S5) were ana-
lyzed. Five injections of the same sample HQT-S1 solution at
different time points (0, 3, 6, 9 and 12 h) were analyzed to evaluate
sample stability. The correlation coefﬁcients between the reference
HPLC ﬁngerprints and the sample HPLC ﬁngerprints were
calculated as a measure of precision, repeatability and stability.
For quantitative analysis, linearity, lower limit of detection
(LLOD) and lower limit of quantiﬁcation (LLOQ), precision
(inter-day and intra-day precision), repeatability, stability, accu-
racy and speciﬁcity were measured and validated according to the
guidelines of the International Conference on Harmonization
(ICH)26. Standard stock solutions containing 11 analytes were
prepared and diluted with methanol to the appropriate concentra-
tions to be used in the calibration curves to evaluate LLOD and
LLOQ. Calibration curves were generated by plotting peak area
against the concentrations of each analyte. The LLOD and LLOQ
of the 11 compounds investigated were deﬁned as the amount for
which the signal-to-noise ratio (S/N) was 3 and 10, respectively.
The intra-day and inter-day precisions of the method were assessed
by performing 6 replicate injections of a mixed standard solution
in day 1 and once daily after that for three consecutive days,
respectively. The reproducibility of this method was determined by
analyzing 6 independently prepared sample solutions (HQT-S10).
The stability was evaluated by repeated analysis of the same
sample solution (HQT-S1) every 3 h for a 12 h time period at
room temperature. Recovery tests were carried out to determine
the accuracy of the method by adding a known amount of the
corresponding marker compound to the known sample (HQT-S5).
Speciﬁcity tests were investigated by using UV spectra and MS
fragmentation. The samples were extracted and analyzed as
described above. The average percent recoveries were evaluated
by calculating the ratio of detected amount versus the added
amount.2.5. Pharmacological studies
Adult male Wistar rats (190–210 g) were purchased from the
Institute of Experimental Animals (Academy of Military Medical
Science; Beijing, China), housed under standard conditions
(2575 1C, 40%–70% relative humidity, 12 h/12 h light–dark cycle)
and fed the standard diet and water ad libitum. Antipyretic and anti-
inﬂammatory activities were evaluated based on the rat pyrexia
models27 and carrageenin-induced rat hind paws oedema, respec-
tively. Speciﬁcally, 1% carrageenin suspension in 0.9% NaCl was
injected into the plantar surfaces of the 2 hind paws (0.1 mL/hind
paw). Following injection, the volume of the right paw was
measured using a YLS-7B Toe Volume Measuring Instrument
(Jinan, China). The rectal temperature was measured 3 times daily
(at 9:00, 15:00 and 21:00) using a Digital Electronic Thermometer
(Shenzhen, China) for 3 days, and only animals with no more than
0.3 1C ﬂuctuations in body temperature were used in the experi-
ments. Sixty rats were randomly assigned into 6 groups of 10 rats
each. The following experimental conditions were used. Control
group: treated with water; reference group: treated with aspirin
(100 mg/kg body weight) dissolved in water, HQT groups: treated
with either extract of HQT-S3, HQT-S4, HQT-S6 or HQT-S8
(7.0 g/kg body weight) dissolved in water. In this study, water,
aspirin and HQT dosages of 1.4 mL/kg body weight were admini-
strated orally once a day for 3 consecutive days. The last treatment
was on day 3, 1 h after the carrageen injection. Response values
were recorded at 0, 1, 2, 3, 4, 6 and 8 h as described above. Changes
Figure 1 HPLC ﬁngerprints of 10 batches of Huangqin Tang (similarity 0.990–1.000).
Flavonoid proﬁling of Huangqin Tang 151in rectal temperature and paw volume were calculated using the
following formula: change in rectal T (1C)¼Tt – T0 h; Changes in
paw volume (mL)¼ (Vt – V0 h), where Tt is the rectal temperature at
different time points and Vt is the volume of the right paw at
different time points. All the rat studies were performed in
accordance with the protocols established by the Animal Care and
Use Committee of the China Academy of Chinese Medical
Sciences.
2.6. Data analysis
Fingerprinting analysis and quantitative determinations were
performed in triplicate. Similarity analysis was performed using
the Similarity Evaluation System for Chromatographic Fingerprint
of TCM software as established by the Chinese Pharmacopoeia
Committee (Version 2008 A). The correlation coefﬁcients of the
chromatographic proﬁles of the samples were calculated and the
reference ﬁngerprint chromatogram was calculated and generated.
Principal component analysis (PCA) was used to sort samples
into groups28 using Simca-P11.0 (Umetrics, Umea, Sweden) to
differentiate and classify the 10 HQT samples based on the
principal peaks. One HQT sample from one group was chosen
and evaluated through the proposed pharmacological method.
The comparison of mean pharmacodynamic values was done
using the Student t-test. A P-value less than 0.05 was considered
signiﬁcant.3. Results
3.1. Fingerprinting analysis of HQT
3.1.1. Method validation
In order to conﬁrm the accuracy of the equipment, we analyzed
5 successive injections of a sample solution and calculated the
correlation coefﬁcients between the reference HPLC ﬁngerprint
and the sample HPLC ﬁngerprints. The values obtained were
0.998, indicating that the accuracy of our measurements was
satisfactory. Five injections of the same sample solution atdifferent time points (0, 3, 6, 9 and 12 h) were analyzed and the
correlation coefﬁcients were calculated to determine whether the
sample solutions were stable during the measurement period. The
values obtained 0.961 (0 h), 0.961 (3 h), 0.961 (6 h), 0.963 (9 h)
and 0.962 (12 h) conﬁrmed that the sample solutions were stable
during the measurement periods. At this point, 5 solutions from the
same sample were prepared using the same method and were
injected individually. The correlation coefﬁcients were 0.999 (0 h),
0.999 (3 h), 0.999 (6 h), 0.999 (9 h), and 0.998 (12 h) demonstrat-
ing the repeatability of the analytical method.3.1.2. Sample analysis
Using the parameters described above, we analyzed the 10 batches
of HQT samples. The HPLC ﬁngerprinting proﬁles are shown in
Fig. 1. We found 26 common peaks (area greater than 0.5% per
chromatogram and common to all chromatograms). Table 1 shows
that the similarity between the values obtained for the 10 samples
was higher than 0.997, except for HQT-S3 for which the similarity
value was 0.990. This indicates a high consistency and stability
between the batches of HQT tested.3.2. Identiﬁcation of the common peaks
3.2.1. Herbal source identiﬁcation
The decoction of HQT and its ingredient herbs (namely Radix
Scutellariae, Radix et Rhizoma Glycyrrhizae, Radix Paeoniae Alba
and Fructus Jujubae) at the concentrations tested were simulta-
neously analyzed using the chromatographic ﬁngerprinting analy-
sis method. Peaks were assigned to each herb by comparing to the
retention time of the peaks in the chromatograms of the individual
herbal ingredients. As shown in Fig. 2, 26 peaks in the HQT
HPLC ﬁngerprint were unique to an individual herbal component.
Speciﬁcally, we found the following number of unique peaks: 22
peaks for Radix Scutellariae, 3 peaks for Radix et Rhizoma
Glycyrrhizae, 1 peak for Radix Scutellariae and Radix et Rhizoma
Glycyrrhizae. These peaks represented 90% of the total area of the
chromatogram from 0 to 80 min at a threshold of 0.5%. Small
Figure 2 HPLC chromatograms of Huangqin Tang (HQT)，Radix Scutellariae (A)，Radix Paeoniae (B)，Radix Rhizoma Glycyrrhizae (C) and
Fructus Jujubae (D). 26 peaks assigned in the HQT HPLC ﬁngerprint were unique to an individual herbal component; 22 peaks from Radix
Scutellariae, 3 peaks from Radix et Rhizoma Glycyrrhizae. 1 common peak is ascribed to Radix Scutellariae and Radix et Rhizoma Glycyrrhizae,
simultaneously. These peaks represented 90% of the total area, summed over the overall chromatogram from 0 to 80 min, at a threshold of 0.5%.
Tao Li et al.152peaks in the HQT HPLC ﬁngerprint were ascribed to Radix
Paeoniae and Fructus Jujubae.3.2.2. Compounds identiﬁcation
As shown in Fig. 3 and Table 2, 11 peaks in the HQT HPLC
ﬁngerprints (8 peaks in spectra at 276 nm and 3 peaks in spectra at
370 nm) were identiﬁed and conﬁrmed using the reference compounds
available. An additional 9 peaks were tentatively identiﬁed using their
UV spectra and MS–MS fragmentation characteristics. The peaks
marked with 3, 10, 11, 15, 18, 22, 24 and 26 were liquiritin, baicalin,
liquiritigenin, oroxylin-A-glucoside, wogonoside, baicalein, wogonin
and oroxylin-A respectively. The peaks marked with 8’, 9’ and 22’
were isoliquiritin apioside, isoliquiritoside and isoliquiritigenin, respec-
tively, which were more readily detected at 370 nm. A list of these
identiﬁed peaks is provided in Supplementary Fig. 1 and Table 1. No
novel compounds were identiﬁed. Peak 2 contains liquiritin apioside, a
ﬁnding that needs to be conﬁrmed in future studies. The 11 conﬁrmed
compounds were chosen as markers for quantitative analysis in ten
batches of HQT samples.3.3. Quantitative analysis of HQT
3.3.1. Method validation
All of the peaks in the HPLC proﬁles obtained from the HQT
batches analyzed contained one compound except for peak 2,
proving the accuracy of our analysis. However, Peak 3 was only
roughly quantiﬁed due to limited peak resolution. A detailed
description of the calibration curve parameters, precision, repro-
ducibility, stability and recovery is presented in Table 3. Good
linearity (R40.999) was achieved within the investigated ranges
for all the analytes tested. The LLOD of the 11 analytes was within
the range of 0.034–0.188 mg/L and LLOQ was within the range of
0.068–0.750 mg/L. The results of intra-day and inter-day preci-
sions, their reproducibility and stability showed that the relative
standard deviation (RSD) values were all less than 4.0%. Therecovery of the method was in the range of 90%–101%, with an
RSD less than 4.0% for all analytes. The validation results
indicated that the system and the HPLC method were excellent
for simultaneous quantitative evaluation of 11 ﬂavonoids in HQT.3.3.2. Sample analysis
The analytical method we developed was successfully applied for
the simultaneous determination of 11 compounds in 10 batches of
HQT obtained from different sources. Table 4 shows the mean
content of each sample, which was analyzed in triplicate and
calculated using the external standard method. The distribution of
the 11 compounds was very similar among the HQT batches
tested. Baicalin was the most common component and isoliquir-
itigenin was the least common in the batches tested. The relative
quantities of the individual components varied with the RSD
value. For example, the content of baicalin was in the range of
5.33%–11.10%, with an RSD value of 18.98%. Although Radix et
Rhizoma Glycyrrhizae is from the same batch, ﬂavonoids of Radix
et Rhizoma Glycyrrhizae showed different distributions in HQT
(RSD value, 6.5%–28.0%). The RSD of the total amount of the 11
components was 13.4972.13%. HQT-S4 contained the greatest
abundance of the 11 components identiﬁed, speciﬁcally baicalin
and wogonoside. HQT-S3 contained the lowest abundance, which
partly explained the low similarity with the other batches tested.
Among the 11 ﬂavonoids identiﬁed, baicalin and wogonoside
contributed more than 84% of the total composition.3.3.3. PCA analysis for the HQT batches
PCA was performed to distinguish the studied samples using the
11 quantiﬁed components identiﬁed. The score plots derived from
the PCA are shown in Fig. 4. For the following study of animal
pharmacodynamic evaluation, the 10 samples could be manually
divided into 4 domains based on the score plots. The ﬁrst domain
was HQT-S3 and HQT-S5, and the second one was HQT-S4,
which is far from the other samples. The third domain was
Figure 3 HPLC proﬁles of Huangqin Tang (HQT) and mixed reference substances (MRS). 8 peaks of spectra at 276 nm (A) and 3 peaks at
370 nm (B) were conﬁrmed. The peaks marked with 3, 10, 11, 15, 18, 22, 24, 26, 8’, 9’ and 22’ were liquiritin, baicalin, liquiritigenin, oroxylin-A-
glucoside, wogonoside, baicalein, wogonin, oroxylin-A, isoliquiritin apioside, isoliquiritoside and isoliquiritigenin. Peak 2 contains liquiritin
apioside, which needs to be conﬁrmed in future studies.
Table 2 LC–MS identiﬁcation of the common peaks in Huangqin Tang samples.
Peak No. Max wave length (nm) [MþH]þ Fragmentation ion Identiﬁcation
2 550 573, 490, 317, 156 Liquirititin apioside
3 280 441 441, 257 Liquiritin
8’ 370 551 573, 515 Isoliquiritin apioside
9’ 370 419 419 Isoliquiritoside
10 285, 340 469 469, 293, 447, 271 Baicalin
11 276 257 257, 138 Liquiritigenin
15 218, 272, 310 483 483, 461, 285, 270 Oroxylin-A-glucoside
18 220, 270 461 461, 285, 270 Wogonoside
22 220, 276, 322 271 271, 188, 106 Baicalein
22’ 240, 300, 370 257 515, 432, 269, 188 Isoliquiritigenin
24 226, 274 285 285, 270 Wogonin
26 274 515 514, 432, 269, 285, 270, 203 Oroxylin-A
Flavonoid proﬁling of Huangqin Tang 153HQT-S1, -S6, -S9 and -S10. The last domain was HQT-S2, -S7
and -S8, which were close to each other.3.4. Anti-inﬂammatory and antipyretic activity of HQT
HQT demonstrated markedly anti-inﬂammatory, antipyretic, and
analgesic efﬁcacy in previous study1. Herein, HQT-S3, -S4, -S6and -S8 were selected for a comparative study of their antipyretic
and anti-inﬂammatory activities. HQT was well-tolerated overall
and had no apparent toxic effects. As shown in Fig. 5, HQT-S3,
-S4 and -S6 showed statistically signiﬁcant decreases in fever
while HQT-S3, -S4, -S6 and -S8 showed statistically signiﬁcant
decreases in paw edema, compared with the control rats. This
study indicates that HQT from different batches has signiﬁcant
antipyretic (all except HQT-S8) and anti-inﬂammatory effects
Tao Li et al.154(Po0.05). No signiﬁcant differences were observed between the
different batches of HQT except for the antipyretic effect of HQT-
S3 and HQT-S4 at 6 h and the anti-inﬂammatory effect of HQT-
S4, HQT-S6 and HQT-S8. For example, the changes in rectal
temperature were 0.6470.46, 0.8070.42, 0.6170.22 and
0.8970.50 1C and the changes in paw volume were 0.0870.05,
0.0670.06, 0.0870.06 and 0.1070.06 mL for HQT-S3, -S4, -S6
and -S8, respectively, at 3 h after the last administration of HQT.
These in vivo results were consistent with the similarities in the
chemical ﬁngerprints between these batches.4. Discussion
4.1. Optimization of HPLC conditions and extraction methods
Here we investigated the following HPLC conditions: mobile phase,
column, detection wavelength and elution program for the optimi-
zation of chromatographic conditions. Two different types of LC
columns were investigated: Aglient Zorbax SB-C18 (250 mm
4.6 mm, 5 μm) and Dikma Diamonsil C18 (2) (250 mm 4.6 mm,
5 μm). The Dikma Diamonsil C18 (2) column was suitable for
analysis because it provided better separation efﬁciency. The
HPLC mobile phase in methanol–water, acetonitrile–water and
the different concentrations of modiﬁers (formic acid and acetic
acid) were investigated. Finally, acetonitrile–water containing 1%
v/v acetic acid was applied for the separation of chemical
constituents in HQT. The UV detector was employed because of
the ﬂavonoid spectra in Radix Scutellariae and Radix et Rhizoma
Glycyrrhizae. The monitoring wavelength was set at 276 nm
for ﬁngerprinting analysis, whereas 276 nm and 370 nm were
simultaneously used for quantitative analysis. Various extraction
methods (ultrasonic extraction, cold-dipping under ambient tem-
perature, hot-dipping in an 80 1C water bath), solvents (water,
methanol and ethanol at different concentrations), and time were
evaluated to obtain the optimized extraction efﬁciency. According
to the total content of the 12 ﬂavonoids, the highest extraction
efﬁciency was obtained with hot-dipping at 75% (v/v) ethanol for
30 min in an 80 1C water bath.
4.2. Quality control
Bioactive, characteristic, main, synergistic, correlative, toxic and
general components are often used as quality control markers of
single medicinal herbs29. The chemical marker is useful for those
herbal medicines of limited and known chemical composition. In
addition to the method speciﬁed in the Chinese Pharmacopoeia,
there are many studies on the quality control of Radix Scutellar-
iae, Radix Paeoniae, Radix et Rhizoma and Glycyrrhizaeand
Fructus Jujubae30–33. In this study, the crude Radix Scutellariae,
Radix Paeoniae, Radix et Rhizoma Glycyrrhizae and Fructus
Jujubae were collected from their authentic regions, identiﬁed by
a senior pharmacist according to the requirements of the Beijing
Food and Drug Administration. In addition, the content of
baicalin in crude Radix Scutellariae was analyzed by HPLC
according to the directions of the Chinese Pharmacopoeia.
However, it is more challenging to ascertain the quality for
TCM prescriptions of HQT than for the single medicinal herbs.
Unexpected differences were to be found in the compatibility
application of the ingredients of HQT after a series of pharma-
ceutical processing, such as decocting, boiling, concentrating and
drying. Chromatographic ﬁngerprinting is a rational and powerfulapproach to characterize a multi-herb formulation with a com-
plicated chemical proﬁle, and HPLC has proven to be a stable,
economical and reliable method for ﬁngerprinting analysis. In
this study, 10 batches of crude Radix Scutellariae collected from
three different regions and processed according to a standard
protocol were analyzed by the HPLC ﬁngerprinting method.
Similarity analysis demonstrated that the 10 batches of HQT
were homogeneous. Twenty-six common peaks were detected
and 11 components were quantiﬁed in the chemical proﬁle of
HQT. The most common components were the ﬂavonoids from
Radix Scutellariae and Radix et Rhizoma Glycyrrhizae (15% of
the weight). The distribution of the 11 biologically active
components was similar between the different batches. Moreover,
our previous studies have shown that 25 (except peak marked 23)
of the 26 common peaks in HQT HPLC proﬁles could enter the
body through the intestine and liver in a perfused intestine–liver
preparation and most of them demonstrate good pharmacokinetic
properties in rats34,35. These compounds have applications in the
treatment of inﬂammation, cancer and gastrointestinal disorders.
Therefore, HPLC ﬁngerprinting together with simultaneous
quantiﬁcation of the identiﬁed ﬂavonoids could be taken into
the consideration for quality control of HQT.
Nevertheless, there are still many components that could not be
detected due to the limitations of our analysis method. For
example, no components were identiﬁed for Radix Paeoniae Alba
and Fructus Jujubae. Furthermore, the absolutely accurate contents
of single or limited constituents maybe not so crucial for the
quality control of herbal medicines. There have been some reports
about the quality control method using the combination of
the chemical proﬁling and pharmacodynamic measurements24,36.
In order to provide a complete picture of the composition of HQT,
a pharmacological evaluation model was used for full quality
assurance. Since an herbal medicine has diverse therapeutic
applications, accurate, sensitive and accessible efﬁcacy indicators
are critical and necessary for their pharmacological evaluation.
HQT possesses a wide range of pharmacological properties such as
anti-inﬂammatory, antipyretic, and analgesic, but in this study we
chose not to focus on the latter. Since both fever and paw edema
were induced on the carrageenin-induced rats, we established a
novel pharmacological model on a single animal for the simulta-
neous evaluation of the antipyretic and anti-inﬂammatory effects
of HQT samples. Out of the different dosages of HQT tested the
dose of 7.0 g/kg body showed the highest efﬁcacy. The PCA
results showed that the 4 batches of HQT were chosen for quality
assurance. No signiﬁcant pharmacological differences were
observed between the different batches of HQT tested, which
indicated consistency in the quality of the different batches,
although the component composition varied between the batches.
Especially, some batches of HQT are even more effective than
aspirin at some points of time. These in vivo results supported the
ﬁndings in chemical ﬁngerprints, suggesting the feasibility and
robustness of current strategy for quality control of HQT.
The methodology of ﬁngerprinting qualitative and quantitative
analysis provides a strategy for the quality control in TCM.
Additionally, an orthogonal pharmacodynamics evaluation would
be a useful and efﬁcient complementary quality control method for
the herbal medicines, especially for those with unclear effective
components. In order to improve the quality control for HQT,
future studies should include more batches of HQT from different
regions to identify and quantify more constituents and to establish
different chromatographic methods. In addition, an evaluation of
the pharmacodynamics at the molecular, cellular, organ and
Table 3 Calibration curve parameters, precision, repeatability, stability and recovery of the 11 compounds in Huangqin Tang.
Compd. Regression equation Linear range
(mg/L)
R LLOD
(mg/L)
LLOQ
(mg/L)
Precision (RSD, %) Repeatability
(RSD, %)
Stability
(RSD, %)
Recovery (%)/RSD (%)
Intra-day Inter-day
Baicalin Y¼24,378Xþ495,617 11.3–2074.0 0.9998 0.13 0.519 2.34 0.19 1.14 1.33 95.59/5.03
Wogonoside Y¼25,476Xþ49,692 2.3–1200.0 0.9998 0.15 0.300 2.05 0.52 1.36 1.15 93.76/4.92
Oroxylin-A-glucoside Y¼30,009Xþ88,403 0.8–750.0 0.9998 0.188 0.750 2.20 0.37 2.3 1.63 91.43/4.95
Baicalein Y¼52,957Xþ249,968 4.2–270.0 0.9992 0.14 0.281 2.38 0.37 1.07 2.27 90.08/3.03
Wogonin Y¼52,362Xþ74,302 1.1–72.4 0.9992 0.065 0.129 2.45 0.18 1.22 2.4 90.09/4.06
Oroxylin-A Y¼36,309Xþ18,262 0.4–27.2 0.9992 0.034 0.068 2.26 1.11 2.33 1.54 90.00/4.00
Liquiritin Y¼18,488Xþ12,364 4.0–129.4 1 0.135 0.539 3.46 1.12 1.49 1.68 92.74/3.83
Isoliquiritin apioside Y¼28,043Xþ1106.9 0.2–6.3 0.9999 0.131 0.524 3.56 1.54 1.6 2.40 101.23/4.51
Liquiritigenin Y¼25,195Xþ1247 0.2–6.4 0.9999 0.134 0.268 2.39 0.87 1.64 2.50 90.03/5.04
Isoliquiritoside Y¼28,572Xþ4600 0.8–24.9 1 0.125 0.498 1.90 1.24 3.28 3.70 90.23/4.30
Isoliquiritigenin Y¼57,958Xþ1310 0.1–2.9 1 0.049 0.196 3.10 1.35 1.22 3.90 99.07/2.55
LLOD, lower limit of determination; LLOQ, lower limit of quantiﬁcation; R, correlation coefﬁcient; RSD, relative standard deviation.
Table 4 Distribution of the 11 components identiﬁed in the batches of Huangqin Tang tested (%) (n¼3).
Parameter Baicalin Wogonoside Oroxylin-A-glucoside Baicalein Wogonin Oroxylin-A Liquiritin Isoliquiritin apioside Liquiritigenin Isoliquiritoside Isoliquiritigenin Total contents
S1 10.4149 2.4179 0.8229 0.6754 0.2215 0.0967 0.3843 0.0354 0.0280 0.0865 0.0049 15.1884
S2 9.8605 2.2262 0.8661 0.4274 0.1619 0.0852 0.3195 0.0340 0.0146 0.0769 0.0041 14.0764
S3 5.3292 1.3881 0.5411 0.6409 0.2280 0.1146 0.3721 0.0314 0.0303 0.0783 0.0037 8.7577
S4 11.1016 2.4815 1.0521 0.3804 0.1303 0.0769 0.3951 0.0367 0.0208 0.0885 0.0043 15.7682
S5 7.5986 1.5775 0.5281 0.7885 0.2510 0.1027 0.3559 0.0315 0.0256 0.0707 0.0040 11.3341
S6 8.1003 2.0687 0.7992 0.7126 0.2338 0.1184 0.3426 0.0323 0.0373 0.0736 0.0040 12.5228
S7 10.6043 2.6353 0.7455 0.6102 0.1381 0.0742 0.3464 0.0258 0.0181 0.0656 0.0038 15.2673
S8 10.094 2.3343 0.9533 0.4114 0.1498 0.0938 0.3444 0.0361 0.0322 0.0607 0.0035 14.5135
S9 9.5884 2.0784 0.7473 0.7917 0.2396 0.1134 0.3815 0.0330 0.0246 0.0683 0.0036 14.0698
S10 8.9704 2.044 0.7966 0.7635 0.2409 0.1238 0.3475 0.0310 0.0222 0.0591 0.0030 13.4020
Min 5.3292 1.3881 0.5281 0.3804 0.1303 0.0742 0.3195 0.0258 0.0146 0.0591 0.0030 8.7577
Max 11.1016 2.6353 1.0521 0.7917 0.2510 0.1238 0.3951 0.0367 0.0373 0.0885 0.0049 15.7682
Mean 9.1662 2.1252 0.7852 0.6202 0.1995 0.1000 0.3589 0.0327 0.0240 0.0728 0.0039 13.4900
RSD, % 18.9828 18.4393 20.6454 25.7002 24.1483 17.5545 6.5431 9.7162 28.0428 13.6757 12.7787 15.8116
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Figure 4 Analysis of the principal components of the 10 batches of Huangqin Tang based on the input data of the principal components. Ten
samples could be manually divided into 4 domains based on the score plots. HQT-S3, -S4, -S6, and -S8 were selected as the markers for the 10
batches for the following pharmacodynamic evaluation.
Figure 5 Antipyretic and anti-inﬂammatory activities of Huangqin Tang (HQT-S3, -S4, -S6 and -S8) at 7.0 g/kg in carrageenan-induced fever
(A) and paw edema (B) in rats (n¼10).
Tao Li et al.156organism level are needed for a comprehensive and credible
evaluation of the compounds.5. Conclusions
In this study, we prepared 10 batches of HQT from different
sources with a standard procedure. We detected 26 common peaks
in the chemical proﬁle of HQT and ascribed by HPLC. Baicalin,
wogonoside, oroxylin-A-glucoside, liquiritin, isoliquiritoside,
liquiritin apioside, isoliquiritin apioside and their aglycones were
identiﬁed and conﬁrmed by LC–MSn. Ten batches of HQT were
homogeneous (similarity higher than 0.990). The total contents of
ﬂavonoids in the different batches of HQT were consistent. The
major components in HQT were baicalin and wogonoside. Finally,
small pharmacodynamic differences between different batches of
HQT samples were found, demonstrating pharmacological homo-
geneity of HQT. In conclusion, the results of this study indicate
that the combination of chromatographic ﬁngerprint and quantita-
tive analysis could be readily utilized as a quality control approach
for the herbal medicines of HQT.Acknowledgments
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